CL2007002391A1 - Use of compounds derived from 2,5-dihydroxybenzene for the treatment of fibrosis. - Google Patents

Use of compounds derived from 2,5-dihydroxybenzene for the treatment of fibrosis.

Info

Publication number
CL2007002391A1
CL2007002391A1 CL2007002391A CL2007002391A CL2007002391A1 CL 2007002391 A1 CL2007002391 A1 CL 2007002391A1 CL 2007002391 A CL2007002391 A CL 2007002391A CL 2007002391 A CL2007002391 A CL 2007002391A CL 2007002391 A1 CL2007002391 A1 CL 2007002391A1
Authority
CL
Chile
Prior art keywords
dihydroxybenzene
fibrosis
treatment
compounds derived
derived
Prior art date
Application number
CL2007002391A
Other languages
Spanish (es)
Inventor
Saenz De Tejada Gorman Inigo
Valverde Lopez Serafin
Maria Lozano Puerto Rosa
Gimenez Gall Guillermo
Cuevas Sanchez Pedro
Original Assignee
Action Medicines Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Action Medicines Sl filed Critical Action Medicines Sl
Publication of CL2007002391A1 publication Critical patent/CL2007002391A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de fibrosis.Use of compounds derived from 2,5-dihydroxybenzene for the treatment of fibrosis.

CL2007002391A 2006-08-16 2007-08-16 Use of compounds derived from 2,5-dihydroxybenzene for the treatment of fibrosis. CL2007002391A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200602218A ES2315118B1 (en) 2006-08-16 2006-08-16 USE OF 2,5-DIHYDROXIBENCENIC COMPOUNDS AND DERIVATIVES IN THE PREPARATION OF USEFUL MEDICINES IN THE TREATMENT OF ROSACEA AND PSORIASIS.

Publications (1)

Publication Number Publication Date
CL2007002391A1 true CL2007002391A1 (en) 2008-01-18

Family

ID=40410124

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007002391A CL2007002391A1 (en) 2006-08-16 2007-08-16 Use of compounds derived from 2,5-dihydroxybenzene for the treatment of fibrosis.

Country Status (2)

Country Link
CL (1) CL2007002391A1 (en)
ES (1) ES2315118B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374772A (en) * 1992-12-08 1994-12-20 Hoffmann-Laroche Inc. Substituted benzoic acids, inhibitors of phospholipases A2
JPH08283152A (en) * 1995-04-12 1996-10-29 Kao Corp Cell adhesion inhibitor
FR2782269B1 (en) * 1998-08-17 2001-08-31 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING SALICYLIC ACID OR A SALICYLIC ACID DERIVATIVE AND USE THEREOF
ES2238924B1 (en) * 2004-02-17 2006-12-01 Investread Europa, S.L. USE OF 2,5-DIHYDROXIBENCENOSULFONIC ACID, IN THE MANUFACTURE OF APPLICATION MEDICINES IN THE TREATMENT OF ANGIODEPENDENT DISEASES.

Also Published As

Publication number Publication date
ES2315118B1 (en) 2009-12-30
ES2315118A1 (en) 2009-03-16

Similar Documents

Publication Publication Date Title
EA200900781A1 (en) 4-PHENYPYRANE-3,5-DIONA, 4-PHENYLTIOPYRANE-3,5-DIONA AND CYCLOHEXANTHRION, AS NEW HERBICIDES
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
EA201000888A1 (en) 4-PHENYPYRANE-3,5-DIONES, 4-PHENYLTYOPYRANE-3,5-DIONS AND 2-PHENYLCYCLOGEXAN-1,3,5-TRIONS AS HERBICIDES
RS52784B (en) Tannate salt of rasagiline
ATE526318T1 (en) FARNESOID-X RECEPTOR AGONISTS
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
CR10157A (en) CHEMICAL COMPOUNDS
CL2012000033A1 (en) Compounds n- (3- (4as, 7as) -2-amino-4a, 5,7,7a-tetrahydro-4h-furo [3,4-d] [1,3] thiazin-7a-yl) -4- fluorophenyl) -5-fluoropiconylamide, bace inhibitor; pharmaceutical composition comprising them, use of the compound for the treatment of Alzheimer's disease.
CL2007003202A1 (en) COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
CL2007002380A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis.
RS54217B1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
CL2007002388A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of hemangiomas or hemangioblastomas.
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
EA200901653A1 (en) PHY-MEDIATED PHKi INHIBITION OF ALPHA-EnaC EXPRESSION
EA200702529A1 (en) FUNGICIDAL COMBINATION OF BIOLOGICALLY ACTIVE SUBSTANCES
EA201000258A1 (en) NEW HERBICIDES
CL2007002890A1 (en) Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
CL2007002920A1 (en) COMPOUNDS DERIVED FROM 2-AMINOCARBONYLPIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007002578A1 (en) COMPOUNDS DERIVED FROM N- (1-FTALAZIN-1-IL-PIPERIDIN-4-IL) -AMIDAS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT AND PREVENTION OF FERTILITY, OSTEOPOROSIS AND CANCER DISORDERS.
EA200971068A1 (en) TRIAZOLYLAMINOPYRIMIDINE COMPOUNDS
CL2007000595A1 (en) Piperidine derived compounds; Pharmaceutical composition and use for the treatment and / or prophylaxis of diseases selected from hypertension, congestive heart failure and renal failure, among others.
CL2008000110A1 (en) USE OF COMPOUNDS DERIVED FROM PIRANONA SUBSTITUTED FOR THE TREATMENT OF METABOLIC SYNDROME; AND COMPOUNDS DERIVED FROM PIRANONA SUBSTITUTED.
CL2007002479A1 (en) COMPOUNDS DERIVED FROM PIRAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.
UA106880C2 (en) NEW HERBICIDES